Follow Us:
Tuesday, August 09, 2022



Couple hopes to crowdfund Rs 16 crore to treat 2-year-old son’s genetic disorder

February 19, 2021 11:27 am

The Novartis manufactured Zolgensma gene therapy to treat spinal muscular atrophy (SMA) is the most expensive medicine globally; it costs 2.1 million US dollars, about Rs 15.24 crore in Indian currency.

Novartis CEO: It’ll take more than vaccine to fight Covid-19

September 30, 2020 3:31 pm

Even once such a vaccine is on the market, he said, it probably won’t protect everyone -- as is the case with seasonal flu.

Novartis to provide 'no profit' COVID-19 drugs to low-income countries

July 16, 2020 11:25 am

Novartis said it would provide medicines ranging from antibiotics and steroids to diarrhea pills to 79 countries on the World Bank's list of low- and lower-middle-income nations.

Novartis $2 million gene therapy for rare disorder is world's most expensive drug

May 25, 2019 9:19 am

Novartis executives defended the price, saying that as a one-time treatment it would ultimately save patients who would have instead been on expensive long-term treatments that cost several hundred thousand dollars a year.

Greek parliament to probe ten politicians over pharma scandal

February 22, 2018 1:42 pm

The politicians to be investigated include current central bank governor and former finance minister Yannis Stournaras and Dimitris Avramopoulos, a European commissioner and former health minister.

Cipla challenges HC order against manufacturing generic drug

January 14, 2015 8:40 am

Cipla had last year started manufacturing and selling a generic drug using the Indacaterol maleate salt.

Judgment reserved on Novartis-Cipla patent dispute

December 17, 2014 1:06 am

Novartis has also sought damages and payment for infringing the patented pharmaceutical product.

Offices biz looks up as firms seek scarce quality addresses

November 04, 2014 11:13 am

Renewed interest among corporate occupiers has led to developers of office spaces asking for higher prices...

Drug regulator slaps penalty on Novartis for overcharging painkiller

October 14, 2014 2:46 am

Last month, the NPPA had withdrawn internal guidelines issued by the drug price regulator to cap prices of non-scheduled drugs.

Novartis drags DRL to US court for patent violation

September 09, 2014 5:39 am

The drug is used as a targeted therapy for treating certain types of leukaemia.